Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
J Vet Diagn Invest ; 35(5): 568-572, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37395186

ABSTRACT

A 12-y-old, male Dachshund was presented for elective orchiectomy. The testes were of normal size. The left testis had numerous dark-red, blood clot-like foci within the vaginal tunic over the pampiniform plexus, epididymis, and testis. Histologically, the red foci were limited to the vaginal tunic and consisted of disorderly growing, variably sized, thin-walled blood vessels lined by a single layer of endothelial cells without mitoses and supported by a thin layer of pericytes. The blood vessels were distended by erythrocytes without thrombus formation. Endothelial cells had cytoplasmic immunolabeling for CD31; pericytes had strong cytoplasmic immunolabeling for α-smooth muscle actin. Our case of subclinical unilateral vascular hamartomas of the vaginal tunic in a dog has not been reported previously in domestic animals or humans, to our knowledge.


Subject(s)
Dog Diseases , Hamartoma , Thrombosis , Humans , Female , Animals , Male , Dogs , Endothelial Cells/pathology , Testis/pathology , Epididymis/pathology , Thrombosis/veterinary , Hamartoma/diagnosis , Hamartoma/veterinary , Hamartoma/pathology , Dog Diseases/diagnosis , Dog Diseases/surgery , Dog Diseases/pathology
2.
Avian Dis ; 66(1): 101-105, 2022 03.
Article in English | MEDLINE | ID: mdl-35308010

ABSTRACT

Resistance to infectious bronchitis (IB) is a polygenic trait, but little is known about how resistance distributes in the host population. In this study, a relatively large number (n = 369) of specific-pathogen-free white leghorn chickens (Gallus gallus) were challenged with an Arkansas -type virulent IB virus (IBV), and resistance was evaluated 5 days after challenge by viral load (IBV RNA) in the trachea and cecal tonsils, as well as by tracheal histomorphometry (mucosal thickness and lymphocyte infiltration). Contrary to expectations, results showed a non-Gaussian distribution of resistance of the whole population against challenge. Indeed, most chickens accumulated toward higher resistance, i.e., lower viral loads and less tracheal damage. The current results also indicated limited differences in resistance to IBV between sexes. Tracheal viral load was significantly higher in males than that in females, but tracheal damage did not significantly differ between sexes. The difference in tracheal viral load found in males and females could have implications for viral spread in commercial chicken populations.


Nota de investigación­Distribución de la resistencia al virus de la bronquitis infecciosa en una población de pollos susceptibles. La resistencia a la bronquitis infecciosa es un rasgo poligénico, pero se sabe poco acerca de cómo se distribuye la resistencia en la población huésped. En este estudio, varios (n=369) pollos White Leghorn libres de patógenos específicos fueron desafiados con un virus de la bronquitis infecciosa virulento de tipo Arkansas y la resistencia se evaluó cinco días después del desafío mediante la carga viral en la tráquea y las tonsilas cecales, así como por histomorfometría traqueal (grosor de la mucosa e infiltración de linfocitos). Contrariamente a lo esperado, los resultados mostraron una distribución no gaussiana de la resistencia de toda la población frente al desafío. De hecho, la mayoría de los pollos se distribuyeron hacia una mayor resistencia, es decir, cargas virales más bajas y menos daño traqueal. Los resultados actuales también indicaron diferencias limitadas en la resistencia al virus de la bronquitis infecciosa entre sexos. La carga viral traqueal fue significativamente mayor en los machos en comparación con las hembras, pero el daño traqueal no fue significativamente diferente entre sexos. La diferencia en la carga viral traqueal encontrada en machos y hembras podría tener implicaciones para la propagación viral en las poblaciones de pollos comerciales.


Subject(s)
Coronavirus Infections , Infectious bronchitis virus , Poultry Diseases , Viral Vaccines , Animals , Chickens , Coronavirus Infections/veterinary , Male , Specific Pathogen-Free Organisms
3.
Avian Dis ; 65(1): 10-17, 2021 03.
Article in English | MEDLINE | ID: mdl-34339116

ABSTRACT

Septicemia-toxemia (sep/tox) falls under U.S. Department of Agriculture (USDA) food safety Category 1 and is the most common and economically significant cause of broiler carcass condemnations. Hepatic lesions are considered a possible consequence of septicemia and associated bacterial contamination of the carcass. Thus, these lesions are considered an indicator of sep/tox (sep/tox hepatitis). This study was undertaken to analyze the histologic lesions preceding grossly visible liver lesions leading to condemnation because of sep/tox at the processing plant. Livers from carcasses of broilers condemned by USDA inspectors for sep/tox were used to establish microscopic and gross criteria of end-stage sep/tox hepatitis. Following the characterization of sep/tox hepatitis, broilers from a farm with a history of sep/tox condemnations were submitted for postmortem examination and bacteriologic investigation at four intervals during the final 20 days of production. Five healthy and five clinically ill chickens were submitted from four houses at 18, 25, 32, and 38 days of production (160 total). Microscopic lesions representing hepatic perisinusoidal myofibroblast proliferation (HPMP), periportal extramedullary granulopoiesis (PEMG), splenic follicular histiocytosis, and bone marrow cellularity (BMC) were graded subjectively for each bird, and subjective grading was evaluated with digital quantitative techniques. Perisinusoidal hepatic stellate cell morphology and progressive transformation of these cells into myofibroblasts was confirmed by immunohistochemistry for smooth muscle actin and desmin. Aerobic cultures of livers and gall bladders from sep/tox birds yielded no growth of bacteria associated with septicemia. Mild to severe HPMP was observed in all age groups, representing 28% of examined birds. Increases in inflammatory cells observed by PEMG and BMC were positively correlated with progressive HPMP and end-stage sep/tox hepatitis in broiler chickens.


Artículo regular­Proliferación de miofibroblastos perisinusoidales hepáticos y respuesta inflamatoria sistémica que precede a la hepatitis por septicemia y toxemia (sep/tox) en pollos de engorde. La septicemia-toxemia (sep/tox) se incluye en la Categoría 1 de seguridad alimentaria del Departamento de Agricultura de los Estados Unidos. (USDA) y es la causa más común y económicamente significativa de decomisos de canales de pollos de engorde. Las lesiones hepáticas se consideran una posible consecuencia de la septicemia y de la contaminación bacteriana asociada con la canal. Por lo tanto, estas lesiones se consideran un indicador de septicemia/toxemia (hepatitis sep/tox). Este estudio se llevó a cabo para analizar las lesiones histológicas que preceden a las lesiones hepáticas muy visibles que conducen a los decomisos debido a septicemia/toxemia en la planta de procesamiento. Se utilizaron hígados de canales de pollos de engorde decomisados por los inspectores del USDA por septicemia/toxemia para establecer criterios microscópicos y generales de hepatitis en etapa terminal de la septicemia/toxemia. Después de la caracterización de la hepatitis por septicemia/toxemia, los pollos de engorde de una granja con un historial de decomisos por septicemia/toxemia se sometieron a examen post mortem e investigación bacteriológica en cuatro intervalos durante los últimos 20 días de producción. Se enviaron cinco pollos sanos y cinco clínicamente enfermos de cuatro casetas a los 18, 25, 32 y 38 días de producción (160 en total). Las lesiones microscópicas que representan la proliferación de miofibroblastos perisinusoidales hepáticos (HPMP), la granulopoyesis extramedular periportal (PEMG), la histocitosis folicular esplénica y la celularidad de la médula ósea (BMC) se clasificaron subjetivamente para cada ave, y la clasificación subjetiva se evaluó con técnicas cuantitativas digitales. La morfología de las células estrelladas hepáticas perisinusoidales y la transformación progresiva de estas células en miofibroblastos se confirmó mediante inmunohistoquímica para actina y desmina del músculo liso. Los cultivos aeróbicos de hígados y vesícula biliar de aves con septicemia/toxemia no produjeron crecimiento de bacterias asociadas con la septicemia. Se observó proliferación de miofibroblastos perisinusoidales hepáticos de leve a severa en todos los grupos de edad, lo que representa el 28% de las aves examinadas. Los aumentos en las células inflamatorias observados por granulopoyesis extramedular periportal y celularidad de la médula ósea se correlacionaron positivamente con proliferación progresiva de miofibroblastos perisinusoidales hepáticos y con hepatitis por septicemia/toxemia en etapa terminal en pollos de engorde.


Subject(s)
Cell Proliferation , Chickens , Hepatitis, Animal/pathology , Liver/pathology , Myofibroblasts/physiology , Poultry Diseases/pathology , Systemic Inflammatory Response Syndrome/veterinary , Animals , Hepatitis, Animal/virology , Poultry Diseases/virology , Sepsis/veterinary , Sepsis/virology , Systemic Inflammatory Response Syndrome/pathology , Systemic Inflammatory Response Syndrome/virology , Toxemia/veterinary , Toxemia/virology
4.
Vet Dermatol ; 29(5): 452-e154, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30091502

ABSTRACT

BACKGROUND: Dermatophytic pseudomycetoma is an atypical form of dermatophytosis where the infection is located in the deep dermal and subcutaneous tissues. Although rare, it is most commonly associated with Microsporum canis or Trichophyton sp. It has been reported in cats, dogs and horses. OBJECTIVES: To describe the clinical and pathological findings of dermatophytic pseudomycetoma caused by M. canis and Trichophyton sp. in two domestic ferrets. ANIMALS: Two pet ferrets (Mustela putorius furo). METHOD AND MATERIALS: Case report. RESULTS: Two ferrets were diagnosed with dermatophytic pseudomycetoma confirmed by histological examination of tissue and fungal culture. In both cases, ferrets presented with several cutaneous firm nodules 0.6-3 cm in diameter. Microscopic lesions revealed multifocal nodular pyogranulomatous inflammation with intralesional fungi. CONCLUSIONS AND CLINICAL IMPORTANCE: To the best of the authors' knowledge, this is the first description of dermatophytic pseudomycetoma in domestic ferrets. This disease should be included in the differential diagnosis of nodular dermatopathies in this species.


Subject(s)
Dermatomycoses/veterinary , Ferrets/microbiology , Microsporum , Tinea/veterinary , Trichophyton , Animals , Dermatomycoses/diagnosis , Dermatomycoses/microbiology , Dermatomycoses/pathology , Male , Skin/microbiology , Skin/pathology , Tinea/diagnosis , Tinea/microbiology , Tinea/pathology
5.
Vaccine ; 35(43): 5864-5871, 2017 10 13.
Article in English | MEDLINE | ID: mdl-28899630

ABSTRACT

The avian coronavirus infectious bronchitis virus (IBV) S1 subunit of the spike (S) glycoprotein mediates viral attachment to host cells and the S2 subunit is responsible for membrane fusion. Using IBV Arkansas-type (Ark) S protein histochemistry, we show that extension of S1 with the S2 ectodomain improves binding to chicken tissues. Although the S1 subunit is the major inducer of neutralizing antibodies, vaccination with S1 protein has been shown to confer inadequate protection against challenge. The demonstrated contribution of S2 ectodomain to binding to chicken tissues suggests that vaccination with the ectodomain might improve protection compared to vaccination with S1 alone. Therefore, we immunized chickens with recombinant trimeric soluble IBV Ark-type S1 or S-ectodomain protein produced from codon-optimized constructs in mammalian cells. Chickens were primed at 12days of age with water-in-oil emulsified S1 or S-ectodomain proteins, and then boosted 21days later. Challenge was performed with virulent Ark IBV 21days after boost. Chickens immunized with recombinant S-ectodomain protein showed statistically significantly (P<0.05) reduced viral loads 5days post-challenge in both tears and tracheas compared to chickens immunized with recombinant S1 protein. Consistent with viral loads, significantly reduced (P<0.05) tracheal mucosal thickness and tracheal lesion scores revealed that recombinant S-ectodomain protein provided improved protection of tracheal integrity compared to S1 protein. These results indicate that the S2 domain has an important role in inducing protective immunity. Thus, including the S2 domain with S1 might be promising for better viral vectored and/or subunit vaccine strategies.


Subject(s)
Coronavirus Infections/immunology , Coronavirus Infections/prevention & control , Infectious bronchitis virus/immunology , Spike Glycoprotein, Coronavirus/immunology , Vaccines, Subunit/immunology , Animals , Antibodies, Viral/immunology , Cell Line , Chickens/immunology , Genetic Vectors/immunology , HEK293 Cells , Humans , Poultry Diseases/immunology , Poultry Diseases/prevention & control , Vaccination/methods , Vaccines, Attenuated/immunology , Viral Load/methods , Viral Vaccines/immunology , Virus Attachment/drug effects
6.
Can Vet J ; 58(7): 703-706, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28698687

ABSTRACT

A 10-year-old castrated male Labrador retriever dog was presented for evaluation of a right elbow mass. Mandibular lymphadenopathy was noted on physical examination. Following sudden death after discharge, a necropsy was performed. Cause of death was determined to be due to hemoabdomen secondary to high grade lymphoma.


Hémoabdomen secondaire à un lymphome de haut grade. Un chien mâle Labrador retriever castré âgé de 10 ans a été présenté pour l'évaluation d'une masse au coude droit. Une lymphadénopathie mandibulaire a été observée à l'examen physique. Après une mort soudaine consécutive au congé, une nécropsie a été réalisée. La cause de la mort a été déterminée comme étant un hémoabdomen secondaire à un lymphome de haut grade.(Traduit par Isabelle Vallières).


Subject(s)
Dog Diseases/diagnosis , Hemorrhage/veterinary , Lymphoma, Non-Hodgkin/veterinary , Animals , Dogs , Fatal Outcome , Hemorrhage/diagnosis , Lymphoma, Non-Hodgkin/complications , Male
7.
Theriogenology ; 90: 245-251, 2017 Mar 01.
Article in English | MEDLINE | ID: mdl-28166975

ABSTRACT

Tritrichomonas foetus is a sexually transmitted reproductive pathogen of cattle that causes transient infertility, early embryonic death, metritis, pyometra, and sporadic abortions. The objective of this research was to assess the impact on reproductive health of vaccinating naïve heifers with a killed T. foetus vaccine (TrichGuard) before experimental exposure followed by breeding. A total of 40 beef heifers were randomly assigned into two treatment groups. Heifers where then vaccinated with two doses of TrichGuard or sham vaccinated with 0.9% sterile saline according to their respective groups. Sixty days following vaccination or sham vaccination, heifers were intravaginally inoculated with 2 × 106 organisms of a cloned isolate of T. foetus of bovine origin (CDTf-4) during synchronized estrus. Three days following inoculation of T. foetus, bulls free of T. foetus were introduced for natural breeding. Three bulls were maintained with the 40 heifers (20 vaccinated; 20 sham vaccinated) for a 49-day breeding season. Cervical mucous samples were obtained from each heifer at Day 0 and at 29 additional time points throughout the study for T. foetus culture. Pregnancy assessments were performed routinely by using transrectal palpation and ultrasonography. Pregnancies were detected in 19/20 (95%) vaccinated heifers and 14/20 (70%) sham-vaccinated heifers (P = 0.046). Only 4/20 (20%) of the sham-vaccinated heifers gave birth to a live calf compared with 10/20 (50%) of the vaccinated heifers (P = 0.048). Thus, embryonic or fetal loss was detected in 9/19 (47%) vaccinated heifers and 10/14 (71%) sham-vaccinated heifers (P = 0.153). The interval of time between inoculations with T. foetus and conceptions of pregnancies that were maintained until birth did not differ significantly between groups (vaccinated = 18.7 days; sham-vaccinated = 17.3 days; P = 0.716). The infectious challenge in this study proved to be very rigorous as a positive culture was detected from all heifers. The culture-positive results on the last culture day did not differ significantly (P = 0.115) between vaccinated heifers (63.9 days) and sham-vaccinated heifers (79.2 days). All uterine culture samples collected from the 26 nonpregnant heifers on Day 207 postinoculation did not result in the detection of T. foetus. These findings indicate that the killed, whole cell vaccine used in this study (TrichGuard) was effective in improving reproductive health evidenced by significantly reducing losses associated with T. foetus infections.


Subject(s)
Abortion, Veterinary/prevention & control , Cattle Diseases/prevention & control , Cattle/parasitology , Fertility , Protozoan Infections, Animal/prevention & control , Protozoan Vaccines/immunology , Tritrichomonas foetus/immunology , Abortion, Veterinary/immunology , Abortion, Veterinary/parasitology , Animals , Cattle Diseases/immunology , Cattle Diseases/parasitology , Female , Male , Pregnancy , Protozoan Infections, Animal/immunology , Vaccination/veterinary
8.
Avian Pathol ; 44(5): 408-20, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26223977

ABSTRACT

Polyvalent infectious bronchitis virus vaccination is common worldwide. The possibility of vaccine interference after simultaneous combined vaccination with Arkansas (Ark) and Massachusetts (Mass)-type vaccines was evaluated in an effort to explain the high prevalence of Ark-type infectious bronchitis virus in vaccinated chickens. Chickens ocularly vaccinated with combinations of Ark and Mass showed predominance of Mass vaccine virus before 9 days post-vaccination (DPV) in tears. Even when Mass and Ark vaccines were inoculated into separate eyes, Mass vaccine virus was able to outcompete Ark vaccine virus. Although Mass vaccine virus apparently had a replication advantage over Ark vaccine in ocular tissues, Ark vaccine virus appeared to have an advantage in spreading to and/or replicating in the trachea. When chickens vaccinated with Ark or Mass vaccine were housed together, Mass vaccine virus was able to spread to Ark-vaccinated chickens, but the Ark vaccine was not detected in Mass-vaccinated chickens. Only Mass vaccine was detected in tears of sentinel birds introduced into groups receiving both vaccines. Furthermore, Ark vaccine virus RNA was not detectable until 10 DPV in most tear samples from chickens vaccinated with both Ark and Mass vaccines at varying Ark vaccine doses, while high concentrations of Mass virus RNA were detectable at 3-7 DPV. In contrast, Ark vaccine virus replicated effectively early after vaccination in chickens vaccinated with Ark vaccine alone. The different replication dynamics of Ark and Mass viruses in chickens vaccinated with combined vaccines did not result in reduced protection against Ark challenge at 21 DPV. Further studies are needed to clarify if the viral interference detected determines differences in protection against challenge at other time points after vaccination.


Subject(s)
Coronavirus Infections/veterinary , Infectious bronchitis virus/immunology , Poultry Diseases/prevention & control , Vaccination , Viral Vaccines/immunology , Animals , Arkansas , Chickens , Coronavirus Infections/prevention & control , Coronavirus Infections/virology , Disease Models, Animal , Infectious bronchitis virus/genetics , Infectious bronchitis virus/isolation & purification , Infectious bronchitis virus/physiology , Massachusetts , Poultry Diseases/virology , RNA, Viral/isolation & purification , Sequence Analysis, DNA , Serogroup , Specific Pathogen-Free Organisms , Vaccines, Combined , Virus Replication
9.
Vet Clin Pathol ; 44(3): 437-41, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25944065

ABSTRACT

A 22-year-old Tennessee Walking Horse mare was presented to the Auburn University Large Animal Teaching Hospital with a 3-day history of lethargy, anorexia, and mild signs of colic. The mare had a several-month history of weight loss and refractory cough. Physical examination revealed an increased respiratory rate, and crackles and wheezes were heard on thoracic auscultation. Thoracic ultrasonographic examination showed disseminated, minor, bilateral comet tail-like lesions on the parietal pleural surfaces. Abdominal ultrasonographic examination was unremarkable. Trans-rectal palpation revealed a firm small colon impaction with concomitant diarrhea. Laboratory data were characterized by a very pronounced acute inflammatory leukogram with severe neutropenia and significant left shift, evidence of hepatocellular damage/necrosis, cholestasis, and possibly mixed metabolic alkalosis and acidosis. On cytologic evaluation of a peritoneal fluid sample, there were many large granular lymphocytes (LGL). Large numbers of LGL were also observed on cytologic examination of a subsequent transtracheal wash. The final cytologic interpretation was disseminated lymphoma with LGL morphology. Due to worsening of the clinical signs and poor prognosis, the mare was euthanized. On necropsy and in histopathologic examination, disseminated lymphoma with LGL morphology was noted in a mesenteric lymph node, lungs, liver, spleen, kidneys, and right dorsal colon. Lymphoma with LGL morphology is rarely diagnosed in the horse. This report provides unique cytologic findings of a case of disseminated lymphoma with LGL morphology in a horse, confirmed with histopathologic evaluation.


Subject(s)
Horse Diseases/pathology , Lymphoma/pathology , Animals , Ascitic Fluid/pathology , Cytodiagnosis/veterinary , Female , Horses , Liver/pathology , Lung/pathology , Lymph Nodes/pathology , Lymphocytes/pathology , Lymphoma/veterinary
10.
Vaccine ; 33(23): 2655-61, 2015 May 28.
Article in English | MEDLINE | ID: mdl-25910920

ABSTRACT

Infectious bronchitis virus (IBV) is an endemic disease of chickens and a major contributor to economic losses for the poultry industry despite vaccination. Recent observations indicated that chicks may have an immature immune system immediately after hatching when vaccinated for IBV. Therefore we hypothesized that early IBV vaccination will generate an immature, poorly protective IBV-specific immune response contributing to immune escape and persistence of IBV. To test this hypothesis the IBV-specific immune response and immune protection were measured in chicks vaccinated at different ages. This demonstrated a delayed production of IgG and IgA plasma antibodies in the 1, 7 and 14-day-old vaccination groups and also lower IgA antibody levels were observed in plasma of the 1-day-old group. Similar observations were made for antibodies in tears. In addition, IgG antibodies from the 1-day-old group had lower avidity indices than day 28 vaccinated birds. The delayed and/or lower antibody response combined with lower IgG avidity indices coincided with increased tracheal inflammation and depletion of tracheal epithelia cells and goblet cells upon IBV field strain challenge. The lack of vaccine-mediated protection was most pronounced in the 1-day-old vaccination group and to a lesser extent the 7-day-old group, while the 14-day-old and older chickens were protected. These data strongly support IBV vaccination after day 7 post hatch.


Subject(s)
Antibodies, Viral/blood , Coronavirus Infections/veterinary , Infectious bronchitis virus/immunology , Poultry Diseases/pathology , Poultry Diseases/prevention & control , Viral Vaccines/administration & dosage , Viral Vaccines/immunology , Age Factors , Animals , Antibody Affinity , Chickens , Coronavirus Infections/pathology , Coronavirus Infections/prevention & control , Immunoglobulin A/blood , Immunoglobulin G/blood , Poultry Diseases/immunology
11.
Theriogenology ; 83(5): 822-31, 2015 Mar 15.
Article in English | MEDLINE | ID: mdl-25515363

ABSTRACT

Prebreeding vaccination should provide fetal and abortive protection against bovine viral diarrhea virus (BVDV) and bovine herpesvirus 1 (BoHV-1) but not impede reproduction when administered to cattle before estrus synchronization and breeding. The objective was to assess reproductive performance when naive beef heifers were vaccinated with modified-live viral (MLV) vaccine 2 days after unsynchronized estrus, and then revaccinated with MLV vaccine at 10 or 31 days before synchronized natural breeding. Sixty beef heifers naive to BVDV and BoHV-1 were randomly assigned to one of four treatment groups. Groups A and B (n = 20 per group) were vaccinated with MLV vaccine containing BVDV and BoHV-1 at 2 days after initial detected estrus, and then revaccinated 30 days later, which corresponded to 10 days (group A) or 31 days (group B) before synchronized natural breeding. Groups C and D (n = 10 per group) served as controls and were vaccinated with an inactivated vaccine that did not contain BVDV or BoHV-1 at the same time points as groups A and B, respectively. Estrous behavior was assessed using radio frequency technology. Estrus synchronization was performed, with initiation occurring at revaccination (groups A and C) or 21 days after revaccination (groups B and D). After synchronization, heifers were submitted to a bull breeding pasture for 45 days. At the end of the breeding period, heifers were assessed for pregnancy using ultrasonography. Progesterone concentrations were evaluated at estrus and 10 days after unsynchronized and synchronized estrus, at initial pregnancy check, and at the end of the study. All pregnant heifers in groups A and B and five pregnant heifers in group C were euthanized between 44 and 62 days of gestation and ovarian and conceptus tissues were assayed for BVDV and BoHV-1. Vaccination with MLV vaccine did not result in significant negative reproductive impact based on the duration of interestrus intervals, proportion of heifers exhibiting estrus within 5 days after synchronization, serum progesterone concentrations, pregnancy rates, and pregnancies in the first 5 days of the breeding season. Bovine viral diarrhea virus and BoHV-1 were not detected in luteal tissue, ovarian tissue, or fetal tissues. Use of MLV vaccine did not impede reproduction, when revaccination was performed at 10 or 31 days before synchronized natural breeding.


Subject(s)
Bovine Virus Diarrhea-Mucosal Disease/prevention & control , Cattle/physiology , Estrus Synchronization , Herpesviridae Infections/veterinary , Pregnancy Rate , Viral Vaccines/immunology , Animals , Cattle/blood , Diarrhea Viruses, Bovine Viral , Dinoprost/administration & dosage , Dinoprost/pharmacology , Estradiol/blood , Female , Gonadotropin-Releasing Hormone/administration & dosage , Gonadotropin-Releasing Hormone/pharmacology , Herpesviridae Infections/prevention & control , Herpesvirus 1, Bovine , Pregnancy , Progesterone/administration & dosage , Progesterone/blood , Progesterone/pharmacology
12.
Vet Microbiol ; 170(3-4): 246-57, 2014 Jun 04.
Article in English | MEDLINE | ID: mdl-24656648

ABSTRACT

Recently, in the United States, a dairy bull was diagnosed as the second confirmed case of persistent testicular infection (PTI) with bovine viral diarrhea virus (BVDV). The first objective of this study was to evaluate the testing methodologies currently used by the artificial insemination industry in order to improve the detection of bulls with PTI. This study evaluated the impact of multiple factors ([1] sample tested, [2] sample handling, [3] assay used, and [4] assay methodology) on the sensitivity of detection of BVDV. The second objective of this study was to evaluate the transmissibility of BVDV from the bull through casual or sexual contact. Results from this study indicate that straws of semen should be transported to the diagnostic laboratory in liquid nitrogen dry shippers. PCR proved to be a more sensitive assay than virus isolation; however, certain PCR protocols exhibited greater diagnostic sensitivity than others. Insemination with cryopreserved semen from this infected bull caused viral transmission to a seronegative heifer resulting in viremia and seroconversion. After 42 months of age, the bull appeared to clear the infection. In conclusion, this bull validates that natural exposure to a 1a strain of BVDV can result in a unique PTI causing contamination of semen with detectable infectious virus. Appropriate handling and testing of samples is necessary in order to detect bulls exhibiting PTI. Additionally, PTI with BVDV may potentially be cleared after an extended duration.


Subject(s)
Bovine Virus Diarrhea-Mucosal Disease/diagnosis , Bovine Virus Diarrhea-Mucosal Disease/transmission , Diarrhea Virus 1, Bovine Viral/physiology , Testicular Diseases/veterinary , Animals , Cattle , Diarrhea Virus 1, Bovine Viral/genetics , Female , Insemination, Artificial/veterinary , Male , Polymerase Chain Reaction , Semen/virology , Testicular Diseases/virology , United States
14.
Can Vet J ; 54(1): 61-4, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23814303

ABSTRACT

Two adult llamas (Lama glama) previously exposed to oak trees (Quercus spp.) were presented with a history of depression and anorexia. Clinicopathological abnormalities included severe gastroenteritis, acute renal failure, and increased liver enzymes. This is believed to be the first report of oak toxicosis in South American camelids.


Insuffisance rénale aiguë chez deux lamas adultes après l'exposition à des chênes (Quercusspp.). Deux lamas adultes (Lama glama) antérieurement exposés aux chênes (Quercus spp.) ont été présentés avec une anamnèse de dépression et d'anorexie. Les anomalies clinicopathologiques incluaient une gastroentérite grave, une insuffisance rénale aiguë et une hausse des enzymes hépatiques. On croit qu'il s'agit du premier rapport sur la toxicose du chêne chez des camélidés d'Amérique du Sud.(Traduit par Isabelle Vallières).


Subject(s)
Acute Kidney Injury/veterinary , Camelids, New World , Plant Poisoning/veterinary , Quercus/poisoning , Acute Kidney Injury/diagnosis , Acute Kidney Injury/etiology , Animals , Fatal Outcome , Male , Plant Poisoning/complications , Plant Poisoning/diagnosis
15.
Avian Dis ; 56(3): 501-8, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23050466

ABSTRACT

Infectious bronchitis coronavirus (IBV) shows extensive genotypic and phenotypic variability. The evolutionary process involves generation of genetic diversity by mutations and recombination followed by replication of those phenotypes favored by selection. In the current study, we examined changes occurring in a wild Arkansas (Ark) challenge strain in chickens that were vaccinated either ocularly with commercially available attenuated ArkDPI-derived vaccines or in ovo with a replication-defective recombinant adenovirus expressing a codon-optimized IBV Ark S1 gene (AdArkIBV.S1(ck)). Commercial IBV Ark vaccines A, B, and C provided slightly differing levels of protection against homologous challenge. Most importantly for the current study, chickens vaccinated with the different vaccines displayed significant differences in specific B-lymphocyte responses in the Harderian gland (i.e., the challenge virus encountered differing immune selective pressure during invasion among host groups). Based on S1 sequences, five predominant populations were found in different individual vaccinated/challenged chickens. Chickens with the strongest immune response (vaccine A) were able to successfully impede replication of the challenge virus in most chickens, and only the population predominant in the challenge strain was detected in a few IBV-positive birds. In contrast, in chickens showing less than optimal specific immune responses (vaccines B and C) IBV was detected in most chickens, and populations different from the predominant one in the challenge strain were selected and became predominant. These results provide scientific evidence for the assumption that poor vaccination contributes to the emergence of new IBV strains via mutation and/or selection. In ovo vaccination with a low dose of AdArkIBV.S1(ck) resulted in a mild increase of systemic antibody and reduced viral shedding but no protection against IBV signs and lesions. Under these conditions we detected only virus populations identical to the challenge virus. Possible explanations are discussed. From a broad perspective, these results indicate that selection is an important force driving IBV evolution.


Subject(s)
Chickens , Coronavirus Infections/veterinary , Infectious bronchitis virus/classification , Viral Vaccines/immunology , Animals , Antibodies, Viral/blood , Coronavirus Infections/pathology , Coronavirus Infections/prevention & control , Coronavirus Infections/virology , Immunoglobulin G/blood , Infectious bronchitis virus/genetics , Trachea/pathology
16.
J Am Vet Med Assoc ; 241(4): 484-95, 2012 Aug 15.
Article in English | MEDLINE | ID: mdl-22852575

ABSTRACT

OBJECTIVE: To determine whether administration of 2 doses of a multivalent, modified-live virus vaccine prior to breeding of heifers would provide protection against abortion and fetal infection following exposure of pregnant heifers to cattle persistently infected (PI) with bovine viral diarrhea virus (BVDV) and cattle with acute bovine herpesvirus 1 (BHV1) infection. DESIGN: Randomized controlled clinical trial. ANIMALS: 33 crossbred beef heifers, 3 steers, 6 bulls, and 25 calves. PROCEDURES: 20 of 22 vaccinated and 10 of 11 unvaccinated heifers became pregnant and were commingled with 3 steers PI with BVDV type 1a, 1b, or 2 for 56 days beginning 102 days after the second vaccination (administered 30 days after the first vaccination). Eighty days following removal of BVDV-PI steers, heifers were commingled with 3 bulls with acute BHV1 infection for 14 days. RESULTS: After BVDV exposure, 1 fetus (not evaluated) was aborted by a vaccinated heifer; BVDV was detected in 0 of 19 calves from vaccinated heifers and in all 4 fetuses (aborted after BHV1 exposure) and 6 calves from unvaccinated heifers. Bovine herpesvirus 1 was not detected in any fetus or calf and associated fetal membranes in either treatment group. Vaccinated heifers had longer gestation periods and calves with greater birth weights, weaning weights, average daily gains, and market value at weaning, compared with those for calves born to unvaccinated heifers. CONCLUSIONS AND CLINICAL RELEVANCE: Prebreeding administration of a modified-live virus vaccine to heifers resulted in fewer abortions and BVDV-PI offspring and improved growth and increased market value of weaned calves.


Subject(s)
Abortion, Veterinary/prevention & control , Bovine Virus Diarrhea-Mucosal Disease/prevention & control , Diarrhea Viruses, Bovine Viral/immunology , Herpesvirus 1, Bovine/immunology , Infectious Bovine Rhinotracheitis/prevention & control , Viral Vaccines/immunology , Animals , Breeding , Cattle , Female , Fetus/virology , Male , Polymerase Chain Reaction/methods , Polymerase Chain Reaction/veterinary , Pregnancy , Pregnancy Rate , Viral Vaccines/administration & dosage
17.
J Vet Diagn Invest ; 24(4): 710-5, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22585953

ABSTRACT

HistoGel™ is an aqueous specimen-processing gel that encapsulates and suspends histologic and cytologic specimens in a solidified medium. HistoGel-embedded specimens can then be processed and evaluated by routine histologic and immunohistochemical methods. This methodology has been used in human diagnostic pathology and is especially useful for small, friable, or viscous tissue samples that are difficult to process. In addition, special histochemical stains or immunohistochemistry can be performed on HistoGel-embedded cytologic specimens using standardized methods developed for histopathology. The current report describes several applications for HistoGel, including use with cytologic specimens, bone marrow aspirates, retention of tissue orientation for endoscopic biopsy specimens, and evaluation of friable tissues. Samples were encapsulated in HistoGel, fixed in 10% neutral buffered formalin, routinely processed, paraffin embedded, and sectioned for histochemical and immunohistochemical evaluation. The results of this study support the use of HistoGel in veterinary diagnostic pathology.


Subject(s)
Histological Techniques/veterinary , Specimen Handling/veterinary , Animals , Cats , Dogs , Histological Techniques/methods , Immunohistochemistry/veterinary , Male , Specimen Handling/methods
18.
Antivir Chem Chemother ; 22(4): 171-9, 2012 Jan 17.
Article in English | MEDLINE | ID: mdl-22182713

ABSTRACT

BACKGROUND: Animals persistently infected (PI) with bovine viral diarrhoea virus (BVDV) are a key source of viral propagation within and among herds. Currently, no specific therapy exists to treat PI animals. The purpose of this research was to initiate evaluation of the pharmacokinetic and safety data of a novel antiviral agent in BVDV-free calves and to assess the antiviral efficacy of the same agent in PI calves. METHODS: One BVDV-free calf was treated with 2-(2-benzimidazolyl)-5-[4-(2-imidazolino)phenyl]furan dihydrochloride (DB772) once at a dose of 1.6 mg/kg intravenously and one BVDV-free calf was treated three times a day for 6 days at 9.5 mg/kg intravenously. Subsequently, four PI calves were treated intravenously with 12 mg/kg DB772 three times a day for 6 days and two PI control calves were treated with an equivalent volume of diluent only. RESULTS: Prior to antiviral treatment, the virus isolated from each calf was susceptible to DB772 in vitro. The antiviral treatment effectively inhibited virus for 14 days in one calf and at least 3 days in three calves. Subsequent virus isolated from the three calves was resistant to DB772 in vitro. No adverse effects of DB772 administration were detected. CONCLUSIONS: Results demonstrate that DB772 administration is safe and exhibits antiviral properties in PI calves while facilitating the rapid development of viral resistance to this novel therapeutic agent.


Subject(s)
Antiviral Agents/therapeutic use , Benzimidazoles/therapeutic use , Bovine Virus Diarrhea-Mucosal Disease/drug therapy , Diarrhea Viruses, Bovine Viral/drug effects , Furans/therapeutic use , Animals , Antiviral Agents/adverse effects , Antiviral Agents/pharmacokinetics , Benzimidazoles/adverse effects , Benzimidazoles/pharmacokinetics , Cattle , Diarrhea Viruses, Bovine Viral/physiology , Dose-Response Relationship, Drug , Drug Resistance, Viral/drug effects , Drug Resistance, Viral/physiology , Furans/adverse effects , Furans/pharmacokinetics , Microbial Sensitivity Tests , Osmolar Concentration , Time Factors
19.
Avian Dis ; 56(4): 642-53, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23397834

ABSTRACT

We investigated the significance of differing proportions of specific subpopulations among commercial Arkansas (Ark) Delmarva poultry industry (DPI) vaccines with regard to vaccination outcome. Two ArkDPI-derived vaccines that contain a higher proportion of viruses with S1 genes that become selected during replication in chickens exhibited more rapid establishment of those selected subpopulations in chickens, produced significantly higher viral loads in tears, and induced higher antibody responses compared with two other ArkDPI vaccines with lower proportions of viruses that become selected in chickens. The presence of higher proportions of selected subpopulations was also associated with a significantly higher incidence of respiratory signs early after vaccination and in some cases more severe tracheal lesions. However, one of the ArkDPI-derived vaccines with a lower proportion of selected subpopulations, despite producing a lower viral load in tears, also induced a higher incidence of respiratory signs later after vaccination and more severe tracheal lesions. Furthermore, one of the ArkDPI-derived vaccines with a higher proportion of selected subpopulations, despite producing a higher viral loads in tears, resulted in less severe tracheal damage. These discrepancies suggest that infectious bronchitis virus (IBV) load in tears may not always predict degree of tracheal damage and that phenotypic characteristics other than S1 may also be involved in severity of vaccine reactions following ArkDPI vaccine administration. We observed lower antibody responses to the vaccines that produced lower viral loads, which might contribute to the persistence of Ark serotype IBV vaccines observed in commercial flocks.


Subject(s)
Chickens , Coronavirus Infections/veterinary , Infectious bronchitis virus/genetics , Poultry Diseases/immunology , Poultry Diseases/virology , Viral Vaccines/immunology , Animals , Antibodies, Viral/metabolism , Coronavirus Infections/immunology , Coronavirus Infections/pathology , Coronavirus Infections/virology , Harderian Gland/virology , Immunoglobulin G/metabolism , Infectious bronchitis virus/classification , Infectious bronchitis virus/isolation & purification , Interferon-gamma/metabolism , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/genetics , Molecular Sequence Data , Poultry Diseases/pathology , RNA, Messenger/genetics , Respiratory System/immunology , Respiratory System/pathology , Respiratory System/virology , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Sequence Analysis, DNA/veterinary , Sequence Analysis, Protein/veterinary , Specific Pathogen-Free Organisms , Spike Glycoprotein, Coronavirus , Tears/virology , Vaccines, Attenuated/genetics , Vaccines, Attenuated/immunology , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics , Viral Load/veterinary , Viral Vaccines/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...